Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein H1 pseudogene 3 (HNRNPH1P3) is a **processed pseudogene** related to the parental gene HNRNPH1, which encodes a member of the heterogeneous nuclear ribonucleoproteins (hnRNPs) family. hnRNPs are RNA-binding proteins involved in pre-mRNA processing, splicing regulation, mRNA stabilization, and other post-transcriptional regulatory processes[2][3][4]. Pseudogenes like HNRNPH1P3 generally do not produce functional proteins, but may potentially exert effects at the RNA level—such as acting as decoys for microRNAs or participating in regulatory networks without being protein-coding[1]. As of current evidence, HNRNPH1P3 itself does not function as a therapeutic or diagnostic target, nor is it reported to be directly involved in disease or interact with any drugs. The functional parent gene, HNRNPH1, plays roles in RNA splicing and has been implicated in several diseases, but these associations do not extend to the HNRNPH1P3 pseudogene based on current scientific understanding[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein H1 pseudogene 3 (HNRNPH1P3).